Q2 2025 Holdings
Filed 2025-08-14 | 40 holdings | $476.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $42.0M | 53,916 | 8.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $40.1M | 927,711 | 8.4% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $34.3M | 409,944 | 7.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $31.1M | 179,926 | 6.5% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $30.8M | 56,674 | 6.5% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $30.6M | 390,932 | 6.4% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $25.2M | 226,875 | 5.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $24.6M | 229,046 | 5.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $19.9M | 601,439 | 4.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $19.7M | 2,104,512 | 4.1% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $19.6M | 1,170,372 | 4.1% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $17.6M | 239,125 | 3.7% |
| Natera Inc(NTRA) | COM | 632307104 | $16.4M | 97,297 | 3.4% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $16.3M | 1,396,445 | 3.4% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $13.9M | 746,527 | 2.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $13.9M | 670,575 | 2.9% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $10.4M | 569,704 | 2.2% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $10.0M | 191,529 | 2.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $7.8M | 213,402 | 1.6% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $7.7M | 162,596 | 1.6% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $6.4M | 672,290 | 1.4% |
| Uniqure NV(QURE) | SHS | N90064101 | $5.8M | 417,443 | 1.2% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $5.7M | 61,507 | 1.2% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $4.9M | 1,626,370 | 1.0% |
| Outset MED Inc(OM) | COM NEW | 690145206 | $3.2M | 166,666 | 0.7% |
| Septerna Inc(SEPN) | COM | 81734D104 | $3.1M | 294,360 | 0.7% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $3.1M | 330,337 | 0.6% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $2.1M | 215,314 | 0.4% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $2.0M | 388,303 | 0.4% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $1.8M | 586,909 | 0.4% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $1.6M | 30,661 | 0.3% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.3M | 188,304 | 0.3% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $908.6K | 97,800 | 0.2% |
| Metagenomi Inc(MGX) | COM | 59102M104 | $782.9K | 528,993 | 0.2% |
| Karyopharm Therapeutics Inc(KPTI) | COM NEW | 48576U205 | $629.3K | 146,013 | 0.1% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $546.9K | 760,035 | 0.1% |
| Mersana Therapeutics Inc | COM | 59045L106 | $464.0K | 1,567,413 | 0.1% |
| Atai Life Sciences NV | SHS | N0731H103 | $431.1K | 196,858 | 0.1% |
| Fractyl Health Inc(GUTS) | COM | 35168W103 | $347.1K | 214,236 | 0.1% |
| Sensei Biotherapeutics Inc(SNSE) | COM NEW | 81728A207 | $126.3K | 14,718 | 0.0% |